Loading

[ 2012/07/17 | Chugai Pharmaceutical Co., Ltd. | Pharmaceuticals | Tokyo | TSE1 ]

Opening of Chugai’s Research Subsidiary


The Company's Official Page
http://www.chugai-pharm.co.jp/hc/ss/english/news/detail/20120717110000.html
Back To Previous Page

Translation

Jul 17, 2012

Opening of Chugai’s Research Subsidiary
“Chugai Pharmabody Research Pte. Ltd.” in Singapore

July 17, 2012- Chugai Pharmaceutical Co., Ltd. [Main Office: Chuo-ku, Tokyo. Chairman & CEO: Osamu Nagayama (hereafter, “Chugai”)] announced that its research subsidiary ”Chugai Pharmabody Research Pte. Ltd.“ (“CPR”) has started its operation. CPR was establish in Singapore in January 2012 as a new company for conducting research focusing on the generation of new antibody drugs by utilizing Chugai’s proprietary innovative antibody engineering technologies.

Attached is a press release by CPR, distributed at its opening ceremony on July 13.

Chugai Expands in Singapore with Opening of Second Satellite Research Institute [ PDF 24KB]



Related Latest News
"Chugai Pharmaceutical Co., Ltd." more
"Pharmaceuticals" Listed Companies more
"Pharmaceuticals" Non-listed Companies more
"Tokyo" Companies more
WARNING: (1) Because this website uses a computer program to automatically collect and display press-release text information, errors or inaccuracy may occur. Double-check with information on these companies' official websites. (2) A press release may contain facts, figures and preliminary forward-looking statements which are subject to change.
Press Conferense Videos
Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays
Sharp Corporation 2012/06/01
More Videos
Latest Press Release Search

Save favorite searches Hot keywords

Fukushima | power supply | cloud | solar
*NOTE: Recommended keywords shown above.
Your Most Recently Viewed Companies
Visit any of the company pages in JPubb, and your most recently viewed companies will automatically show up here.

Erase all This feature:ON How to use
Latest Releases: Chugai Pharmaceutical Co., Ltd.
Anti-Cancer Agent, Herceptin　Obtained Approval for Dosage and Administration for　Postoperative Adjuvant Chemotherapy in Breast Cancer
2013/06/14
Anti-Cancer Agent “Tarceva,”　Obtained Approval for Additional Indication (First Line Therapy) of　Non-Small Cell Lung Cancer with EGFR Mutations
2013/06/14
Anti-Cancer Agent “Avastin," Obtained Approval for Additional Indication and Dosage and Administration of Malignant Glioma
2013/06/14
Roche’s RoACTEMRA Shows Long-Term Efficacy
2013/06/13
Roche’s RoACTEMRA Approved in EU
2013/06/10
Feed
Releases by Prefecture
Hokkaido | Aomori | Iwate | Miyagi | Akita | Yamagata | Fukushima

Ibaraki | Tochigi | Gunma | Saitama | Chiba | Tokyo | Kanagawa

Niigata | Toyama | Ishikawa | Fukui | Yamanashi | Nagano

Gifu | Shizuoka | Aichi | Mie

Shiga | Kyoto | Osaka | Hyogo | Nara | Wakayama

Tottori | Shimane | Okayama | Hiroshima | Yamaguchi

Tokushima | Kagawa | Ehime | Kochi

Fukuoka | Saga | Nagasaki | Kumamoto | Oita | Miyazaki | Kagoshima | Okinawa
Releases by Stock Exchange
TSE (Tokyo) All | TSE1 | TSE2 | Mothers

OSE (Osaka) All | OSE1 | OSE2 | JASDAQ Standard | JASDAQ Growth

NSE (Nagoya) All | NSE1 | NSE2 | Centrex | NSE-only

SSE (Sapporo) All | Ambitious | SSE-only

FSE (Fukuoka) All | Q-Board | FSE-only
Press Release Search
Company
Industry
Prefecture
Stock Exchange
Date
(yyyy/mm/dd)		 //～
//
Listed or Non-listed
*NOTE: Please input only items to be specified.
*NOTE: The "date" here means the one on which a press release is uploaded on this website. So it isn't necessarily the same as its official announcement date.
Company Search
Company
Industry
Prefecture
Stock Exchange
Listed or Non-listed
*NOTE: Please input only items to be specified.